Wolff-Parkinson-White Syndrome Differential Diagnoses

  • Author: Christopher Randall Ellis, MD; Chief Editor: Jeffrey N Rottman, MD   more...
 
Updated: Feb 14, 2012
 
 

Diagnostic Considerations

Wolff-Parkinson-White (WPW) syndrome can result in supraventricular tachycardia (SVT) that uses an arteriovenous (AV) accessory pathway (AP). The AP may also act as an innocent bystander and allow conduction during other supraventricular dysrhythmias, such as atrial fibrillation (AF) or atrial flutter. Paradoxically, the use of digoxin and perhaps other AV nodal blocking agents may favor conduction through the AP, causing potentially lethal ventricular dysrhythmias (ventricular fibrillation [VF]) or hemodynamic instability during AF.

The most common mechanism in pediatric patients is AP-mediated SVT, which is a reentrant tachycardia. The main differential during SVT is whether the AP is concealed (ie, conducts only from ventricle to atrium) and thus is an SVT with narrow QRS.

An automatic mechanism may be differentiated from reentry by the following:

  • Presence of a warmup or cool-down period (which is due to its relation with catecholamine levels)
  • Inability to initiate or terminate SVT with programmed atrial stimulation
  • Usual unresponsiveness to electrical cardioversion

A regular tachycardia of sudden onset and termination that allows for some cycle-length oscillation (which can be usually initiated and terminated with programmed atrial stimulation) and that is usually responsive to electrical cardioversion favors a reentrant mechanism.

Differential diagnosis of accessory pathway syndromes

Few entities that involve paroxysms of SVT with a WPW pattern electrocardiogram (ECG) in sinus rhythm may be differentiated from AP-mediated SVT. Examples include the following:

  • Low atrial focus, which occasionally produces the appearance of a short PR interval
  • Atriofascicular APs (so-called Mahaim fibers)
  • Lown-Ganong-Levine (LGL) syndrome

The term “Mahaim fibers” refers to atriofascicular bypass tracts that connect the right atrium to the distal right bundle (see the image below). These pathways usually represent a duplication of the AV node and the distal conducting system. They typically occupy the right ventricular free wall. Their proximal end resides adjacent to the lateral tricuspid annulus and exhibits slow conduction, with AV node–like characteristics. The distal end, which conducts rapidly, inserts into the distal right bundle branch or the apical region of the right ventricle.

Variants of Wolff-Parkinson-White syndrome (unusuaVariants of Wolff-Parkinson-White syndrome (unusual accessory pathways).

If Mahaim fibers are present, the ECG findings are a normal or long PR interval and an abnormally wide QRS complex with a left-bundle appearance. Preexcitation may not be apparent during sinus rhythm but can be demonstrated with premature right atrial stimulation. Because retrograde conduction is absent, only an antidromic AV reentry tachycardia (ie, preexcited tachycardia) can develop.

In the presence of atriofascicular tracts, preexcited tachycardia has a left bundle-branch block (LBBB) pattern, a long AV interval (due to the long conduction time over the accessory pathway), and short ventriculoatrial (VA) intervals. If right bundle-branch block (RBBB) develops, it may prolong the tachycardia cycle length (slow the atrioventricular reentrant tachycardia [AVRT]). Any right free wall bypass tract-mediated SVT will be prolonged with RBBB but should be unaffected by LBBB aberrancy.

Conversely, left free wall bypass tract AVRT will slow with LBBB (ipsilateral to the accessory pathway). Septal pathways may be slightly affected by either RBBB (anteroseptal) or LBBB (posteroseptal), but this would be detected only on electrophysiologic study (EPS). The eponym Coumel is also applied to this rule.

Given the pathway length and decremental conduction properties (similar to AV nodal conduction), a preexcited QRS complex with a short PR interval essentially rules out Mahaim fibers.

In LGL syndrome, patients have a short PR interval and SVT but no delta wave. This is typically caused by an atrio-Hisian pathway leading to accelerated AV conduction, but not causing paroxysmal SVT. In patients with LGL syndrome who have an atrio-Hisian tract, the QRS complex remains normal and the short atrio-Hisian interval remains fixed during atrial pacing at rapid rates.

Entities that involve wide-QRS SVT must be differentiated from ventricular tachycardia (VT). Examples include the following:

  • Aberrantly conducting orthodromic SVT, which is wide-QRS SVT with the AV node as the antegrade limb but with bundle branch block, must be differentiated from VT.
  • Antidromic tachycardia, which is wide-QRS SVT due to ventricular preexcitation through an AP, must also be differentiated from VT and from Mahaim fiber tachycardia.

Sometimes, accessory AV fibers connect to the AV node itself or the His bundle or bundle branches and insert into the ventricular myocardium. These are called nodoventricular or fasciculoventricular tracts. Patients with fasciculoventricular connections show a short His-ventricle (HV) interval and no change in the QRS complex during rapid atrial pacing. Fasciculoventricular AV pathways do not participate in clinically meaningful arrhythmias.

Other forms of tachycardia in patients with WPW syndrome

Patients with WPW syndrome can have other tachycardias where the AP is just a bystander, such as atrioventricular nodal reentrant tachycardia (AVNRT) or atrial tachycardia that conducts to the ventricle over the bypass tract.

Atrial flutter or AF may also occur in the atrium, unrelated to the AP, and can conduct rapidly to the ventricle. Patients with WPW syndrome who have AF frequently have inducible reciprocating tachycardias. Interruption of the AP with ablation may or may not prevent recurrence of the AF.

AF presents a potentially serious risk. It typically has a cycle length of 120-200 ms or 300-500 bpm. Atrial flutter is typically at a cycle length of 200 ms or 300 bpm. At rapidly conducted rates (ie, a rate faster than 250 bpm or an AP refractory period shorter than 240 ms), the risk of sudden death occurs as a result of potential conversion from rapid AF to VF. However, such a phenomenon is uncommon, occurring at an estimated frequency of about less than 0.1%.

Patients who have intermittent preexcitation or those who lose ECG evidence of preexcitation abruptly with exercise or when injected intravenously with procainamide generally have a long AP refractory period. These patients are thought to have a low risk of developing a rapid ventricular rate should atrial flutter or AF develop (see the image below).

Preexcited atrial fibrillation. Preexcited atrial fibrillation.

Differential Diagnoses

Proceed to Workup
 
 
Contributor Information and Disclosures
Author

Christopher Randall Ellis, MD  Assistant Professor of Medicine, Cardiac Electrophysiology, Vanderbilt Heart and Vascular Institute, Vanderbilt University School of Medicine; Attending Physician, Adult Cardiovascular Medicine, Veterans Affairs Medical Center-Nashville, Tennessee Valley Healthcare System

Christopher Randall Ellis, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Cardiology, and Heart Rhythm Society

Disclosure: Nothing to disclose.

Coauthor(s)

Hugh D Allen, MD  Professor, Department of Pediatrics, Division of Pediatric Cardiology and Department of Internal Medicine, Ohio State University College of Medicine

Hugh D Allen, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, American Pediatric Society, American Society of Echocardiography, Society for Pediatric Research, Society of Pediatric Echocardiography, and Western Society for Pediatric Research

Disclosure: Nothing to disclose.

Charles I Berul, MD  Professor of Pediatrics and Integrative Systems Biology, George Washington University School of Medicine; Chief, Division of Cardiology, Children's National Medical Center

Charles I Berul, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American Heart Association, Cardiac Electrophysiology Society, Heart Rhythm Society, Pediatric and Congenital Electrophysiology Society, and Society for Pediatric Research

Disclosure: Johnson & Johnson Consulting fee Consulting

Robert Murray Hamilton, MD, MSc, FRCPC  Section Head, Electrophysiology, Senior Associate Scientist, Physiology and Experimental Medicine, Labatt Family Heart Centre; Professor, Department of Pediatrics, University of Toronto Faculty of Medicine

Robert Murray Hamilton, MD, MSc, FRCPC is a member of the following medical societies: American Heart Association, Canadian Cardiovascular Society, Canadian Medical Association, Canadian Medical Protective Association, Cardiac Electrophysiology Society, Heart Rhythm Society, Ontario Medical Association, Pediatric Electrophysiology Society, Royal College of Physicians and Surgeons of Canada, and Society for Pediatric Research

Disclosure: Nothing to disclose.

M Silvana Horenstein, MD  Assistant Professor, Department of Pediatrics, University of Texas Medical School at Houston; Medical Doctor Consultant, Legacy Department, Best Doctors, Inc

M Silvana Horenstein, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, and American Medical Association

Disclosure: Nothing to disclose.

Shubhayan Sanatani, MD  Associate Professor, Department of Pediatrics, University of British Columbia Faculty of Medicine; Consulting Staff, Division of Pediatric Cardiology, British Columbia Children's Hospital, Canada

Shubhayan Sanatani, MD is a member of the following medical societies: British Columbia Medical Association, Canadian Cardiovascular Society, Canadian Heart Rhythm Society, Canadian Heart Rhythm Society, Canadian Medical Association, and Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Specialty Editor Board

Russell F Kelly  MD, Assistant Professor, Department of Internal Medicine, Rush Medical College; Chairman of Adult Cardiology and Director of the Fellowship Program, Cook County Hospital

Russell F Kelly is a member of the following medical societies: American College of Cardiology

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Brian Olshansky, MD  Professor of Medicine, Department of Internal Medicine, University of Iowa College of Medicine

Brian Olshansky, MD is a member of the following medical societies: American Autonomic Society, American College of Cardiology, American College of Chest Physicians, American College of Physicians, American College of Sports Medicine, American Federation for Clinical Research, American Heart Association, Cardiac Electrophysiology Society, Heart Rhythm Society, and New York Academy of Sciences

Disclosure: Guidant/Boston Scientific Honoraria Speaking and teaching; Medtronic Honoraria Speaking and teaching; Guidant/Boston Scientific Consulting fee Consulting; Novartis Honoraria Speaking and teaching; Novartis Consulting fee Consulting

Stuart Berger, MD  Professor of Pediatrics, Division of Cardiology, Medical College of Wisconsin; Chief of Pediatric Cardiology, Medical Director of Pediatric Heart Transplant Program, Medical Director of The Heart Center, Children's Hospital of Wisconsin

Stuart Berger, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Cardiology, American College of Chest Physicians, American Heart Association, and Society for Cardiac Angiography and Interventions

Disclosure: Nothing to disclose.

Chief Editor

Jeffrey N Rottman, MD  Professor of Medicine and Pharmacology, Vanderbilt University School of Medicine; Chief, Department of Cardiology, Nashville Veterans Affairs Medical Center

Jeffrey N Rottman, MD is a member of the following medical societies: American Heart Association and North American Society of Pacing and Electrophysiology (NASPE)

Disclosure: Nothing to disclose.

References
  1. Wolff, L., Parkinson, J., White, PD. Bundle-branch block with short P-R interval in healthy young people prone to paroxysmal tachycardia. American Heart Journal. 1930/08;5:685-704.

  2. Durrer D, Schuilenburg RM, Wellens HJ. Pre-excitation revisited. Am J Cardiol. Jun 1970;25(6):690-7. [Medline].

  3. Calkins H, Sousa J, el-Atassi R, et al. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med. Jun 6 1991;324(23):1612-8. [Medline].

  4. Pappone C, Vicedomini G, Manguso F, et al. Risk of malignant arrhythmias in initially symptomatic patients with wolff-Parkinson-white syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation. Feb 7 2012;125(5):661-8. [Medline].

  5. Pappone C, Santinelli V, Manguso F, Augello G, Santinelli O, Vicedomini G. A randomized study of prophylactic catheter ablation in asymptomatic patients with the Wolff-Parkinson-White syndrome. N Engl J Med. Nov 6 2003;349(19):1803-11. [Medline].

  6. Sethi KK, Dhall A, Chadha DS, Garg S, Malani SK, Mathew OP. WPW and preexcitation syndromes. J Assoc Physicians India. Apr 2007;55 Suppl:10-5. [Medline].

  7. Ehtisham J, Watkins H. Is Wolff-Parkinson-White syndrome a genetic disease?. J Cardiovasc Electrophysiol. Nov 2005;16(11):1258-62. [Medline].

  8. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med. Jun 14 2001;344(24):1823-31. [Medline].

  9. Brembilla-Perrot B, Yangni N'da O, Huttin O, Chometon F, Groben L, Christophe C. Wolff-Parkinson-White syndrome in the elderly: clinical and electrophysiological findings. Arch Cardiovasc Dis. Jan 2008;101(1):18-22. [Medline].

  10. Zhang Y, Wang L. Atrial vulnerability is a major mechanism of paroxysmal atrial fibrillation in patients with Wolff-Parkinson-White syndrome. Med Hypotheses. 2006;67(6):1345-7. [Medline].

  11. Szumowski L, Walczak F, Urbanek P, Szufladowicz E, Ratajska E, Kepski R, et al. Risk factors of atrial fibrillation in patients with Wolff-Parkinson-White syndrome. Kardiol Pol. Mar 2004;60(3):206-16; discussion 217. [Medline].

  12. Bromberg BI, Lindsay BD, Cain ME, Cox JL. Impact of clinical history and electrophysiologic characterization of accessory pathways on management strategies to reduce sudden death among children with Wolff-Parkinson-White syndrome. J Am Coll Cardiol. Mar 1 1996;27(3):690-5. [Medline].

  13. Attoyan C, Haissaguerre M, Dartigues JF, Le Métayer P, Warin JF, Clémenty J. [Ventricular fibrillation in Wolff-Parkinson-White syndrome. Predictive factors]. Arch Mal Coeur Vaiss. Jul 1994;87(7):889-97. [Medline].

  14. Mark DG, Brady WJ, Pines JM. Preexcitation syndromes: diagnostic consideration in the ED. Am J Emerg Med. Sep 2009;27(7):878-88. [Medline].

  15. Fengler BT, Brady WJ, Plautz CU. Atrial fibrillation in the Wolff-Parkinson-White syndrome: ECG recognition and treatment in the ED. Am J Emerg Med. Jun 2007;25(5):576-83. [Medline].

  16. Arruda, Mauricio S., et al. Development and validation of an ECG algorithm for identifying accessory pathway ablation site in Wolff-Parkinson-White syndrome. Journal of Cardiovascular Electrophysiology. 1998/01;9:2-12.

  17. Burnes JE, Taccardi B, Rudy Y. A noninvasive imaging modality for cardiac arrhythmias. Circulation. Oct 24 2000;102(17):2152-8. [Medline]. [Full Text].

  18. Ghosh S, Avari JN, Rhee EK, Woodard PK, Rudy Y. Hypertrophic cardiomyopathy with preexcitation: insights from noninvasive electrocardiographic imaging (ECGI) and catheter mapping. J Cardiovasc Electrophysiol. Nov 2008;19(11):1215-7. [Medline]. [Full Text].

  19. Pappone C, Manguso F, Santinelli R, Vicedomini G, Sala S, Paglino G. Radiofrequency ablation in children with asymptomatic Wolff-Parkinson-White syndrome. N Engl J Med. Sep 16 2004;351(12):1197-205. [Medline].

  20. Sarubbi B, D'Alto M, Vergara P, Calvanese R, Mercurio B, Russo MG, et al. Electrophysiological evaluation of asymptomatic ventricular pre-excitation in children and adolescents. Int J Cardiol. Feb 15 2005;98(2):207-14. [Medline].

  21. Duszanska A, Lenarczyk R, Kowalski O, Streb W, Kukulski T, Kalarus Z. Evaluation of left ventricular systolic and diastolic function in patients with atrioventricular re-entrant tachycardia treated by radiofrequency current ablation. Acta Cardiol. Apr 2008;63(2):221-7. [Medline].

  22. Jackman WM, Wang XZ, Friday KJ, et al. Catheter ablation of accessory atrioventricular pathways (Wolff- Parkinson-White syndrome) by radiofrequency current. N Engl J Med. Jun 6 1991;324(23):1605-11. [Medline].

  23. Pappone C, Radinovic A, Santinelli V. Sudden death and ventricular preexcitation: is it necessary to treat the asymptomatic patients?. Curr Pharm Des. 2008;14(8):762-5. [Medline].

Previous
Next
 
Classic Wolff-Parkinson-White electrocardiogram with short PR, QRS >120 ms, and delta wave.
Preexcited atrial fibrillation.
Variants of Wolff-Parkinson-White syndrome (unusual accessory pathways).
Accessory pathway potential and local AV fusion at successful RF ablation site with loss of preexcitation and return of normal HV interval.
Electrocardiogram of asymptomatic 17-year-old male who was incidentally discovered to have Wolff-Parkinson-White pattern. It shows sinus rhythm with evident preexcitation. To locate accessory pathway (AP), initial 40 ms of QRS (delta wave) is evaluated. Note that delta wave is positive in I and aVL, negative in III and aVF, isoelectric in V1, and positive in rest of precordial leads. Therefore, this is likely posteroseptal AP.
12-lead electrocardiogram from asymptomatic 7-year-old boy with Wolff-Parkinson-White pattern. Delta waves are positive in I and aVL; negative in II, III, and aVF; isoelectric in V1; and positive in rest of precordial leads. This predicts posteroseptal location for accessory pathway.
12-lead electrocardiogram showing short PR interval and delta waves consistent with presence of accessory pathway.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.